DHR logo

Danaher Corporation (DHR)

$225.77

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on DHR

Market cap

$158.84B

EPS

6.12

P/E ratio

39

Price to sales

6.15

Dividend yield

0.709%

Beta

0.737156

Price on DHR

Previous close

$229.91

Today's open

$228.49

Day's range

$225.07 - $231.30

52 week range

$160.93 - $242.80

Profile about DHR

CEO

Julie Sawyer Montgomery

Employees

60000

Headquarters

Washington, DC

Exchange

New York Stock Exchange

Shares outstanding

703530815

Issue type

Common Stock

DHR industries and sectors

Healthcare

Biotechnology & Life Sciences

News on DHR

Danaher Targets Faster Growth With Acquisitions, AI and a Diagnostics Push

Danaher NYSE: DHR is focusing on commercial execution, innovation and acquisitions as it seeks faster core growth and market-share gains, company leader Julie said during a discussion with Tycho Peterson of the Life Science team.

news source

MarketBeat • 16 hours ago

news preview

Danaher Corporation (DHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Danaher Corporation (DHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Nov 17, 2026

news preview

VTRS or DHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two stocks presents investors with the better value opportunity right now?

news source

Zacks Investment Research • Nov 10, 2026

news preview

Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in Focus

Danaher NYSE: DHR President and CEO Julie Sawyer Montgomery said the company is aiming for faster core growth and market share gains through stronger commercial execution, innovation and acquisitions, as it pursues a leadership position in life sciences and diagnostics.

news source

MarketBeat • Nov 10, 2026

news preview

Danaher Corporation (DHR) Presents at 2026 UBS Global Healthcare Conference Transcript

Danaher Corporation (DHR) Presents at 2026 UBS Global Healthcare Conference Transcript

news source

Seeking Alpha • Nov 9, 2026

news preview

Danaher to Present at UBS Global and Jefferies Global Healthcare Conferences

WASHINGTON, Nov. 2, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Julie Sawyer Montgomery, will be presenting at the UBS Global Healthcare Conference in Palm Beach, Florida on Monday, November 9, 2026 at 11:45 a.m. ET and Jefferies Global Healthcare Conference in London, UK on November 17, 2026 at 10:00 a.m.

news source

PRNewsWire • Nov 2, 2026

news preview

Danaher (DHR) Upgraded to Buy: Here's Why

Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news source

Zacks Investment Research • Oct 27, 2026

news preview

Danaher Q3 Recap: Decent Results, Still A Hold

Danaher Corporation is rated hold, as the stock trades at a small premium and offers an 8.85% expected return, below my threshold. Q3 earnings showed solid performance: revenue up 8.3% YoY to $6.55B, adjusted EPS of $2.11, and strong segment growth, especially in Diagnostics. Key headwinds include respiratory revenue volatility and pricing pressure from China's volume-based procurement, despite some recent positive trends.

news source

Seeking Alpha • Oct 22, 2026

news preview

LH vs. DHR: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

news source

Zacks Investment Research • Oct 22, 2026

news preview

Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves

Danaher Corp. (NYSE:DHR) on Wednesday reported third-quarter adjusted earnings of $2.11 per share, beating the analyst consensus estimate of $1.92.

news source

Benzinga • Oct 21, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Danaher Corporation

Open an M1 investment account to buy and sell Danaher Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in DHR on M1